How can drug developers streamline the challenge of getting quality clinical supplies to the clinical sites without delays? Transforming IMP into Clinical Supply: An Integrated Approach takes a look at this important issue and explores:

• How to mitigate clinical supply challenges through early collaboration with an integrated solutions partner
• The key issues that sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs
• A more tailored approach to formulation strategies for complex and challenging compounds
• A focus on user-friendly dosage forms is leading to greater engagement with outsourcing partners earlier in development timelines